BillsHH.R. 9661

To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.

119th CongressIntroduced July 14, 2026Rep. Langworthy, Nicholas A. [R-NY-23]· NY-23
Stage
In committee
Latest action
Referred to the House Committee on Energy and Commerce.
July 14, 2026

Committees

  • PrimaryEnergy and Commerce Committee

Action history

  1. July 14, 2026Introduced in House
  2. July 14, 2026Introduced in House
  3. July 14, 2026Referred to the House Committee on Energy and Commerce.

Cosponsors (1)